Cancer Genetics closes $46 million follow-on

By BC Staff | Oct 29, 2013 | 12:46 AM GMT

Diagnostic company Cancer Genetics Inc. (NASDAQ:CGIX) closed a follow-on with $46 million --

Read the full 130 word article

How to gain access

Continue reading with a
two-week free trial.